Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange:…
Hassan Spine & Sports Medicine Rebrands as NefraHealth
New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing…
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
Carterra Launches Industrys First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional…
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis
Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform…
R1 Appoints Andy Brailo as Chief Commercial Officer
February 06, 2026 11:00 ET | Source: R1 RCM Holdco Inc. CHICAGO,…
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
February 06, 2026 09:25 ET | Source: Ernexa Therapeutics Inc. CAMBRIDGE, Mass.,…
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass.,…
